Our Newsroom
This is the place to get the latest exciting news about Route 92 medical.
Route 92 Medical Enrolls First Patient in SUMMIT RISE Study
SUMMIT RISE is expected to enroll up to 500 patients to evaluate the performance of Route 92 Medical’s neurovascular intervention device portfolio WEST JORDAN, Utah, March 9, 2026 – (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced enrollment of […]
View More
Route 92 Medical Receives Australian Therapeutic Goods Administration Approval for itsPortfolio of Neurovascular Interventional Products for Treating Patients with Acute Ischemic Stroke
View More
First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat IdiopathicIntracranial Hypertension
View More
Route 92 Medical Files Patent Infringement Suit Against Q’Apel Medical
View More